Richard Stewart
2017
In 2017, Richard Stewart earned a total compensation of $208.3K as Chairman and Chief Executive Officer at OncoGenex Pharmaceuticals.
Compensation breakdown
| Salary | $208,333 |
|---|---|
| Total | $208,333 |
Stewart received $208.3K in salary, accounting for 100% of the total pay in 2017.
Rankings
In 2017, Richard Stewart's compensation ranked 13,981st out of 14,666 executives tracked by ExecPay. In other words, Stewart earned more than 4.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,981 out of 14,666 | 5th |
Division Manufacturing | 5,484 out of 5,772 | 5th |
Major group Chemicals And Allied Products | 1,968 out of 2,075 | 5th |
Industry group Drugs | 1,641 out of 1,731 | 5th |
Industry In Vitro and In Vivo Diagnostic Substances | 68 out of 72 | 6th |
Source: SEC filing on April 19, 2018.
Stewart's colleagues
We found four more compensation records of executives who worked with Richard Stewart at OncoGenex Pharmaceuticals in 2017.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019